ASIX:NYE-AdvanSix Inc. (USD)

EQUITY | Chemicals | New York Stock Exchange

Last Closing

USD 28.6

Change

+1.05 (+3.81)%

Market Cap

USD 0.58B

Volume

0.22M

Analyst Target

USD 20.00
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

AdvanSix Inc manufactures Nylon 6, a polymer resin used to produce engineered plastics, fibers, filaments & films that are used in end-products as automotive & electronic components, carpets, sports apparel, fishing nets & food and industrial packaging.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-03-28 )

Largest Industry Peers for Chemicals

Symbol Name Price(Change) Market Cap
DOW Dow Inc

+0.85 (+1.51%)

USD 42.26B
CE Celanese Corporation

+0.60 (+0.39%)

USD 18.14B
BCHMF Bachem Holding AG

-0.33 (-0.38%)

USD 7.16B
HUN Huntsman Corporation

+0.32 (+1.35%)

USD 4.46B
MXCHY Orbia Advance Corp

-0.38 (-10.24%)

USD 4.41B
BAK Braskem SA Class A

+0.22 (+2.52%)

USD 3.51B
TROX Tronox Holdings PLC

+0.11 (+0.63%)

USD 2.56B
REX REX American Resources Corpora..

+0.82 (+1.46%)

USD 1.03B
WLKP Westlake Chemical Partners LP

-0.06 (-0.27%)

USD 0.77B
LXU Lsb Industries Inc

+0.08 (+0.98%)

USD 0.62B

ETFs Containing ASIX

N/A

Market Performance

  Market Performance vs. Industry/Classification (Chemicals) Market Performance vs. Exchange (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -4.54% 20% F 16% F
Dividend Return 0.53% 27% F 32% F
Total Return -4.01% 20% F 16% F
Trailing 12 Months  
Capital Gain -23.75% 13% F 10% F
Dividend Return 1.67% 9% A- 24% F
Total Return -22.09% 13% F 10% F
Trailing 5 Years  
Capital Gain 0.11% 54% F 44% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 0.11% 38% F 27% F
Average Annual (5 Year Horizon)  
Capital Gain 29.93% 82% B 91% A-
Dividend Return 30.41% 82% B 90% A-
Total Return 0.48% 22% F 12% F
Risk Return Profile  
Volatility (Standard Deviation) 79.95% 45% F 10% F
Risk Adjusted Return 38.04% 73% C 64% D
Market Capitalization 0.58B 27% F 50% F

Key Financial Ratios

  Ratio vs. Industry/Classification (Chemicals) Ratio vs. Market (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 5.30 73% 59%
Price/Book Ratio 1.00 73% 70%
Price / Cash Flow Ratio 6.45 40% 50%
Price/Free Cash Flow Ratio 6.49 47% 54%
Management Effectiveness  
Return on Equity 7.39% 60% 46%
Return on Invested Capital 6.24% 73% 50%
Return on Assets 2.91% 67% 55%
Debt to Equity Ratio 23.00% 92% 77%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Low debt

The company is less leveraged than its peers ,, and is among the top quartile, which makes it more flexible. However, do check the news and look at its sector. Sometimes this is low because the company is not growing and has no growth potential.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:
Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector